A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions, according to the results from a phase II clinical trial.

An investigational therapeutic vaccine showed clinical effectiveness in patients with human papillomavirus (HPV)16-positive ...

Discover how the HPV vaccine is changing cancer prevention for both men and women with remarkable protection rates.

Choosing to vaccinate preteens and teens today can spare future generations from the pain and challenges of preventable ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical lesions ...

Learn essential information about the relationship between HPV and oral cancer, including prevention strategies, symptoms, ...

With 90 to 95 per cent of cervical cancer cases caused by the human papillomavirus (HPV), vaccination offers a nearly 99 per cent protection rate against the disease. Prince Court Medical Centre ...

The Human Papillomavirus HPV accounts for about 5 of all cancer cases But does that mean that all HPV infections lead to ...

A mum who battled cervical cancer is hopeful the disease could be eradicated in the next generation. Around six women in ...

The quadrivalent HPV vaccine, developed by multinational pharmaceutical company Merck, was approved on Jan 8 for males on the Chinese mainland. The vaccine targets HPV types 6, 11, 16 and 18. The ...

Mongolia has so far vaccinated at least 20682 children aged 11 against human papillomavirus HPV as part of a nationwide campaign according to a re ...

A therapeutic vaccine targeting human papillomavirus type 16 (HPV16) induced regression in high-grade precancerous cervical ...